Paradoxical preservation of a lipopolysaccharide response in C3H/HeJ macrophages: Induction of matrix metalloproteinase-9

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3596-3600

  Jin, Fen yu ^a,b   Nathan, Carl F ^a   Ding, Aihao ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GELATINASE B; NITRIC OXIDE; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL IMMUNITY; CELL LINE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNOREGULATION; IMMUNOSTIMULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLELES; ANIMALS; CELL LINE; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MACROPHAGES, PERITONEAL; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C3H; THIOGLYCOLATES; TRANSCRIPTION, GENETIC;

EID: 0033559491     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Weiel, J. E., T. A. Hamilton, and D. O. Adams. 1986. LPS induces altered phosphate labeling of proteins in murine peritoneal macrophages. J. Immunol. 136: 3012.
2. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
3. Sweet, M. J., and D. A. Hume. 1996. Endotoxin signal transduction in macrophages. J. Leukocyte Biol. 60:8.
4. Han, J., Y. Jiang, Z. Li, V. V. Kravchenko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kianse p38 in inflammation. Nature 386:296.
5. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.
6. Sultzer, B. M. 1968. Genetic control of leukocyte responses to endotoxin. Nature 219:1253.
7. Watson, J., R. Riblet, and B. A. Taylor. 1977. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J. Immunol. 118:2088.
8. Watson, J., K. Kelly, M. Largen, and B. A. Taylor. 1978. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J. Immunol. 120:422.
9. Glode, L. M., and D. L. Rosenstreich. 1976. Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles. J. Immunol. 117:2061.
10. Watson, J., and R. Riblet. 1974. Genetic control of responses to bacterial lipopolysaccharides in mice I. Evidence for a single gene that influences mitogenic and immunogenic rcsponcs to lipopolysaccharides. J. Exp. Med. 140:1147.
11. Koenig, S., M. K. Hoffmann, and L. Thomas. 1977. Induction of phenotypic lymphocyte differentiation in LPS unresponsive mice by an LPS-induced serum factor and by lipid A-associated protein. J. Immunol. 118:1910.
12. Liang, P., and A. B. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967.
13. Jin, F. Y., C. Nathan, D. Radzioch, and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88:417.
14. Jin, F. Y., C. Nathan, and A. Ding. 1998. Identification of genes in innate responsiveness to bacterial products by differential display. Methods 16:396.
15. Cox, G. W., B. J. Mathieson, L. Gandino, E. Blasi, D. Radzioch, and L. Varesio. 1989. Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J. Natl. Cancer Inst. 81:1492.
16. Blasi, E., D. Radzioch, S. K. Durum, and L. Varesio. 1987. A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage functions. Eur. J. Immunol. 17:1491.
17. Beutler, B., N. Krochin, I. W. Milsark, C. Luedke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977.
18. Akagawa, K. S., K. Kamoshita, S. Onodera, and T. Tokunaga. 1987. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-γ or a calcium ionophore. Jpn. J. Cancer Res. 78:279.
19. Vogel, S. N., L. L. Weedon, L. M. Wahl, and D. L. Rosenstreich. 1982. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. II. T cell modulation of macrophage sensitivity to LPS in vitro. Immunobiology 160:479.
20. Corcoran, M. L., W. G. Stetler-Stevenson, D. L. De Witt, and L. M. Wahl. 1994. Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Arch. Biochem. Biophys. 310:481.
21. Gottschall, P. E., X. Yu, and B. Bing. 1995. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J. Neurosci. Res. 42:335.
22. d) macrophages. J. Immunol. 153:2653.
23. Abu-Lawi, K. I., and B. M. Sultzer. 1995. Induction of serine and threonine protein phosphorylation by endotoxin-associated protein in murine resident peritoneal macrophages. Infect. Immun. 63:498.
24. Vogel, S. N., R. N. Moore, J. D. Sipe, and D. L. Rosenstreich. 1980. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. J. Immunol. 124:2004.
25. d (endotoxin resistance) phenotype. J. Exp. Med. 164:1791.
26. d) mice respond to bacterial lipopolysaccharide by activating NF-κB. J. Leukocyte Biol. 57:174.
27. Gibbs, L. S., P. J. Del Vecchio, and J. B. Shaffer. 1992. Mn and Cu/Zn SOD expression in cells from LPS-sensitive and LPS-resistant mice. Free Radical Biol. Med. 12:107.
28. Duc Dodon, M., and S. N. Vogel. 1985. Analysis of effects of lipopolysaccharide and interferon on murine macrophages: modulation of elastase secretion in vitro. J. Immunol. 49:709.
29. Zhang, Y., D. L. DeWitt, T. B McNeely, S. M. Wahl, and L. M. Wahl. 1997. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2 and matrix metalloproteinases. J. Clin. Invest. 99:894.
30. Bernhard, E. J., S. B. Gruber, and R. J. Muschel. 1994. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA 91:4293.
31. Hurwitz, A., M. Dushnik, H. Solomon, A. Ben-Chetrit, Z. Finci-Yeheskel, A. Milwidsky, M. Mayer, E. Y. Adashi, and S. Yagel. 1993. Cytokine-mediated regulation of rat ovarian function: interleukin-1 stimulates the accumulation of a 92-kilodalton gelatinase. Endocrinology 132:2709.
32. Matrisian, L. M. 1992. The matrix-degrading metalloproteinases. Bioessays 14: 455.
33. La Fleur, M., J. L. Underwood, D. A. Rappolee, and Z. Werb. 1996. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184:2311.
34. Wilhelm, S. M., I. E. Collier, B. L. Marmer, A. Z. Eisen, G. A. Grant, and G. I. Goldberg. 1989. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. [Published erratum appears in 1990, J. Biol. Chem. 265:22570]. J. Biol. Chem. 264:17213.
35. Hamdy, F. C., E. J. Fadlon, D. Cottam, J. Lawry, W. Thurrell, P. B. Silcocks, J. B. Anderson, J. L. Williams, and R. C. Rees. 1994. Matrix metalloproteinase 9 expression in primary human prostatic aderocarcinoma and benign prostatic hyperplasia. Br. J. Cancer. 69:177.
36. Kossakowska, A. E., S. J. Urbanski, S. A. Huchcroft, and D. R. Edwards. 1992. Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. Oncol. Res. 4:233.
37. Mignatti, P., and D. B. Rifkin. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:161.
38. Damsky, C. H., and Z. Werb. 1992. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr. Opin. Cell Biol. 4:772.
39. Ingalls, R. R., and D. T. Golenbock. 1995. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp. Med. 181:1473.
40. Nowak, R. 1995. Entering the postgenome era. Science 270:368.
41. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, X. D. C. Van Huffel, D. Birdwell E. Alejos, M. Silva, M. F. C. Galanos, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:2085.
42. Qureshi, S. T., L. Larivière, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. In press.
43. Wright, S. D. 1999. Toll, a new piece in the puzzle of innate immunity. J. Exp. Med. In press.